Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2019 · 10-Q
Revenue$14.85M$14.85M−0.5% vs Q2 2018 Net Income-$10.29M-$10.29MN/M vs Q2 2018 EPS Diluted-$0.18-$0.18N/M vs Q2 2018 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$10,354,745N/M Margins · derivedGross margin4.9%+31.9 pt vs Q2 2018
Operating margin-69.9%+12.6 pt vs Q2 2018
Net margin-69.3%+12.7 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 9, 2019 · 40 d after period end